Brief: HCW Biologics Reports Fourth Quarter Results
28/03/2022 15:11
March 28 (Reuters) - HCW Biologics Inc HCWB.O :
* HCW BIOLOGICS INC - ESTIMATES THAT IT HAS SUFFICIENT CASH
TO
FUND OPERATION EXPENSES TO END OF 2023
Source text for Eikon: ID:nGNX3SzvW2
Further company coverage: HCWB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Hcw Biologics
See all newsBrief: HCW Biologics Proposed Resale Of Up To 5.69 Million Shares Of Common Stock
Brief: HCW Biologics To Regain Full Rights For Two Commercial-Ready Reagents From Wugen
Brief: HCW Biologics Prices Private Placement Of 2.8 Mln Units At $1.405 Per Unit
NASDAQ RESUMED AT 09:59 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:54 AM